Annual ROE
325.43%
+724.86%+181.47%
31 December 2023
Summary:
Heron Therapeutics annual return on equity is currently 325.43%, with the most recent change of +724.86% (+181.47%) on 31 December 2023. During the last 3 years, it has risen by +396.42% (+558.42%). HRTX annual ROE is now at all-time high.HRTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
76.79%
-67.45%-46.76%
30 September 2024
Summary:
Heron Therapeutics quarterly return on equity is currently 76.79%, with the most recent change of -67.45% (-46.76%) on 30 September 2024. Over the past year, it has dropped by -660.68% (-89.59%). HRTX quarterly ROE is now -97.94% below its all-time high of 3719.39%, reached on 30 June 2023.HRTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRTX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +181.5% | -89.6% |
| 3 y3 years | +558.4% | +166.5% |
| 5 y5 years | +556.1% | +232.9% |
HRTX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +181.5% | -97.9% | +102.7% |
| 5 y | 5 years | at high | +181.5% | -97.9% | +102.7% |
| alltime | all time | at high | +181.5% | -97.9% | +102.7% |
Heron Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 76.79%(-46.8%) |
| June 2024 | - | 144.24%(-39.9%) |
| Mar 2024 | - | 240.19%(-38.9%) |
| Dec 2023 | 325.43%(-181.5%) | 393.20%(-46.7%) |
| Sept 2023 | - | 737.47%(-80.2%) |
| June 2023 | - | 3719.39%(-232.2%) |
| Mar 2023 | - | -2813.80%(+258.1%) |
| Dec 2022 | -399.43%(+184.2%) | -785.85%(+60.3%) |
| Sept 2022 | - | -490.31%(+54.8%) |
| June 2022 | - | -316.80%(+57.5%) |
| Mar 2022 | - | -201.10%(+43.8%) |
| Dec 2021 | -140.53%(+98.0%) | -139.81%(+21.1%) |
| Sept 2021 | - | -115.45%(+17.8%) |
| June 2021 | - | -98.04%(+20.2%) |
| Mar 2021 | - | -81.58%(+15.4%) |
| Dec 2020 | -70.99%(+34.2%) | -70.72%(+5.1%) |
| Sept 2020 | - | -67.31%(+14.3%) |
| June 2020 | - | -58.87%(+3.0%) |
| Mar 2020 | - | -57.13%(-5.3%) |
| Dec 2019 | -52.91%(-25.8%) | -60.34%(+4.4%) |
| Sept 2019 | - | -57.78%(+6.1%) |
| June 2019 | - | -54.48%(-6.1%) |
| Mar 2019 | - | -58.05%(-7.0%) |
| Dec 2018 | -71.35%(-80.1%) | -62.44%(-28.2%) |
| Sept 2018 | - | -87.00%(-31.9%) |
| June 2018 | - | -127.75%(-44.3%) |
| Mar 2018 | - | -229.41%(-25.4%) |
| Dec 2017 | -359.44%(+0.5%) | -307.44%(-30.1%) |
| Sept 2017 | - | -439.98%(+4.8%) |
| June 2017 | - | -420.02%(+10.2%) |
| Mar 2017 | - | -381.11%(+16.8%) |
| Dec 2016 | -357.52%(+231.9%) | -326.37%(+78.7%) |
| Sept 2016 | - | -182.65%(+59.5%) |
| June 2016 | - | -114.51%(+16.2%) |
| Mar 2016 | - | -98.57%(+7.2%) |
| Dec 2015 | -107.73%(-6.9%) | -91.94%(+4.4%) |
| Sept 2015 | - | -88.09%(-5.1%) |
| June 2015 | - | -92.82%(-19.3%) |
| Mar 2015 | - | -114.96%(+10.3%) |
| Dec 2014 | -115.70%(+26.4%) | -104.25%(-3.2%) |
| Sept 2014 | - | -107.67%(-7.9%) |
| June 2014 | - | -116.85%(-16.0%) |
| Mar 2014 | - | -139.16%(+6.5%) |
| Dec 2013 | -91.56%(+32.5%) | -130.68%(+6.8%) |
| Sept 2013 | - | -122.39%(+10.3%) |
| June 2013 | - | -110.92%(+22.6%) |
| Mar 2013 | - | -90.45%(+14.5%) |
| Dec 2012 | -69.11%(-50.1%) | -78.97%(-8.4%) |
| Sept 2012 | - | -86.24%(-26.4%) |
| June 2012 | - | -117.21%(+0.4%) |
| Mar 2012 | - | -116.73%(+9.3%) |
| Dec 2011 | -138.43%(-23.6%) | -106.84%(-1.7%) |
| Sept 2011 | - | -108.74%(-11.7%) |
| June 2011 | - | -123.12%(-56.6%) |
| Mar 2011 | - | -283.53%(+64.0%) |
| Dec 2010 | -181.11%(+30.0%) | -172.90%(-7.9%) |
| Sept 2010 | - | -187.73%(+0.4%) |
| June 2010 | - | -187.07%(-0.4%) |
| Mar 2010 | - | -187.91%(-20.8%) |
| Dec 2009 | -139.34%(+11.7%) | -237.33%(+0.8%) |
| Sept 2009 | - | -235.34%(+16.8%) |
| June 2009 | - | -201.45%(+33.8%) |
| Mar 2009 | - | -150.57%(+15.2%) |
| Dec 2008 | -124.76%(+28.5%) | -130.66%(+14.7%) |
| Sept 2008 | - | -113.92%(+33.7%) |
| June 2008 | - | -85.19%(+11.8%) |
| Mar 2008 | - | -76.17%(-4.0%) |
| Dec 2007 | -97.09%(-268.4%) | -79.38%(+0.8%) |
| Sept 2007 | - | -78.78%(-9.5%) |
| June 2007 | - | -87.02%(-28.2%) |
| Mar 2007 | - | -121.22%(-480.4%) |
| Dec 2006 | 57.67% | 31.87%(-39.3%) |
| Sept 2006 | - | 52.53%(-27.1%) |
| June 2006 | - | 72.04%(-25.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2006 | - | 96.53%(-223.4%) |
| Dec 2005 | -80.66%(+11.2%) | -78.25%(+24.5%) |
| Sept 2005 | - | -62.83%(+12.6%) |
| June 2005 | - | -55.78%(-0.3%) |
| Mar 2005 | - | -55.96%(-16.6%) |
| Dec 2004 | -72.56%(+122.2%) | -67.10%(+8.0%) |
| Sept 2004 | - | -62.13%(+7.0%) |
| June 2004 | - | -58.05%(+2.4%) |
| Mar 2004 | - | -56.68%(+77.8%) |
| Dec 2003 | -32.65%(+49.6%) | -31.88%(+44.6%) |
| Sept 2003 | - | -22.05%(+5.9%) |
| June 2003 | - | -20.83%(+23.9%) |
| Mar 2003 | - | -16.81%(-24.3%) |
| Dec 2002 | -21.82%(+75.0%) | -22.20%(-23.4%) |
| Sept 2002 | - | -28.97%(+101.9%) |
| June 2002 | - | -14.35%(+16.7%) |
| Mar 2002 | - | -12.30%(-1.6%) |
| Dec 2001 | -12.47%(-124.2%) | -12.50%(+7.5%) |
| Sept 2001 | - | -11.63%(-133.3%) |
| June 2001 | - | 34.92%(-14.3%) |
| Mar 2001 | - | 40.76%(-23.6%) |
| Dec 2000 | 51.53%(-358.0%) | 53.33%(+16.0%) |
| Sept 2000 | - | 45.97%(-261.6%) |
| June 2000 | - | -28.44%(+42.5%) |
| Mar 2000 | - | -19.96%(-2.3%) |
| Dec 1999 | -19.97%(-29.0%) | -20.43%(+44.7%) |
| Sept 1999 | - | -14.12%(-2.6%) |
| June 1999 | - | -14.50%(-10.3%) |
| Mar 1999 | - | -16.16%(-17.8%) |
| Dec 1998 | -28.13%(+18.8%) | -19.66%(+371.5%) |
| Sept 1998 | - | -4.17%(-67.7%) |
| June 1998 | - | -12.93%(-44.6%) |
| Mar 1998 | - | -23.34%(-5.6%) |
| Dec 1997 | -23.68%(-87.2%) | -24.73%(-56.0%) |
| Sept 1997 | - | -56.21%(-29.1%) |
| June 1997 | - | -79.25%(-17.6%) |
| Mar 1997 | - | -96.15%(-26.6%) |
| Dec 1996 | -184.31%(+66.7%) | -130.92%(-1.4%) |
| Sept 1996 | - | -132.75%(+9.2%) |
| June 1996 | - | -121.56%(+8.1%) |
| Mar 1996 | - | -112.42%(+19.1%) |
| Dec 1995 | -110.59%(+25.8%) | -94.38%(+46.7%) |
| Sept 1995 | - | -64.35%(-1.0%) |
| June 1995 | - | -65.01%(-8.2%) |
| Mar 1995 | - | -70.85%(-12.2%) |
| Dec 1994 | -87.89%(+36.3%) | -80.70%(-3.3%) |
| Sept 1994 | - | -83.47%(+6.9%) |
| June 1994 | - | -78.05%(+5.6%) |
| Mar 1994 | - | -73.91%(+13.8%) |
| Dec 1993 | -64.50%(+34.8%) | -64.97%(+31.0%) |
| Sept 1993 | - | -49.61%(+28.7%) |
| June 1993 | - | -38.54%(+31.9%) |
| Mar 1993 | - | -29.22%(-17.8%) |
| Dec 1992 | -47.86%(-47.1%) | -35.53%(-16.1%) |
| Sept 1992 | - | -42.33%(-30.8%) |
| June 1992 | - | -61.14%(-21.8%) |
| Mar 1992 | - | -78.22%(-14.1%) |
| Dec 1991 | -90.53%(+83.4%) | -91.10%(+46.3%) |
| Sept 1991 | - | -62.27%(+15.0%) |
| June 1991 | - | -54.14%(-5.0%) |
| Mar 1991 | - | -56.98%(+18.2%) |
| Dec 1990 | -49.37%(+25.1%) | -48.22%(-1.8%) |
| Sept 1990 | - | -49.09%(+19.0%) |
| June 1990 | - | -41.24%(+16.6%) |
| Mar 1990 | - | -35.38%(+0.2%) |
| Dec 1989 | -39.47%(+20.4%) | -35.31%(-10.4%) |
| Sept 1989 | - | -39.39%(-4.7%) |
| June 1989 | - | -41.33%(-8.4%) |
| Mar 1989 | - | -45.11%(+20.0%) |
| Dec 1988 | -32.79%(+48.4%) | -37.59%(+65.8%) |
| Sept 1988 | - | -22.67%(+8.3%) |
| June 1988 | - | -20.93%(+5.9%) |
| Mar 1988 | - | -19.77%(-10.5%) |
| Dec 1987 | -22.09% | -22.09% |
FAQ
- What is Heron Therapeutics annual return on equity?
- What is the all time high annual ROE for Heron Therapeutics?
- What is Heron Therapeutics annual ROE year-on-year change?
- What is Heron Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Heron Therapeutics?
- What is Heron Therapeutics quarterly ROE year-on-year change?
What is Heron Therapeutics annual return on equity?
The current annual ROE of HRTX is 325.43%
What is the all time high annual ROE for Heron Therapeutics?
Heron Therapeutics all-time high annual return on equity is 325.43%
What is Heron Therapeutics annual ROE year-on-year change?
Over the past year, HRTX annual return on equity has changed by +724.86% (+181.47%)
What is Heron Therapeutics quarterly return on equity?
The current quarterly ROE of HRTX is 76.79%
What is the all time high quarterly ROE for Heron Therapeutics?
Heron Therapeutics all-time high quarterly return on equity is 3719.39%
What is Heron Therapeutics quarterly ROE year-on-year change?
Over the past year, HRTX quarterly return on equity has changed by -660.68% (-89.59%)